Page last updated: 2024-08-17

adenosine diphosphate and Cardiovascular Diseases

adenosine diphosphate has been researched along with Cardiovascular Diseases in 76 studies

Research

Studies (76)

TimeframeStudies, this research(%)All Research%
pre-19906 (7.89)18.7374
1990's8 (10.53)18.2507
2000's29 (38.16)29.6817
2010's27 (35.53)24.3611
2020's6 (7.89)2.80

Authors

AuthorsStudies
Hu, X; Liu, C; Zhang, M; Zhang, W1
Lai, W; Liu, Y; Shen, Y; Wan, R; Zhang, D1
Chatzigiannis, CM; Gkalpinos, V; Kostagianni, AD; Kostomitsopoulos, N; Papakyriakopoulou, P; Tellis, CC; Tselepis, AD; Tsiailanis, AD; Tzakos, AG; Valsami, G1
Bachschmid, MM; Baka, T; Balschi, JA; Colucci, WS; Croteau, D; He, H; Luptak, I; Panagia, M; Pimentel, DR1
Gager, GM; Hengstenberg, C; Jilma, B; Kolesnik, E; Lang, IM; Prüller, F; Siller-Matula, JM; Toma, A; von Lewinski, D; Wallner, M; Winter, MP1
Bonello, L; Frere, C; Laine, M1
Just, SA; Nielsen, C; Nielsen, CB; Nybo, M; Vinholt, PJ1
Chen, J; Chen, SY; Lian, JJ; Luo, TC; Zeng, XQ1
Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Seidinger, D; Steiner, S4
Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Steiner, S; Xhelili, E1
Galuszka, J; Hlusi, A; Hutyra, M; Indrak, K; Indrakova, J; Krcova, V; Slavik, L; Ulehlova, J1
Eichelberger, B; Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S1
Andrenacci, E; Biscaglia, S; Campo, G; Ferrari, R; Ferri, A; Pavasini, R; Tebaldi, M1
Bradfield, PF; Chanson, M; Denis, JF; Fontana, P; Imhof, BA; Kwak, BR; Laird, DW; Meens, MJ; Molica, F; Monyer, H; Morel, S; Penuela, S; Zufferey, A1
Cattaneo, M1
Hoffmann, K; von Kügelgen, I1
Agu, RU; Kolathuru, SS; Yeung, PK1
Aslam, A; Boland, J; Connor, DE; Jarvis, S; Joseph, JE; Low, J; Ly, K; Muller, DW1
Abdalla, FH; Bagatini, MD; Baldissarelli, J; Cardoso, AM; Dalenogare, DP; Dos Santos, DL; Martins, CC; Morsch, VM; Schetinger, MR; Zanini, D1
Anstrom, KJ; Baker, BA; Cohen, DJ; Effron, MB; Henry, TD; McCoy, LA; Messenger, JC; Peterson, ED; Wang, TY; Zettler, ME1
Becker, DM; Becker, LC; Boerwinkle, E; Brody, JA; Chen, MH; Cupples, LA; Eicher, JD; Faraday, N; Gibbs, RA; Johnson, AD; Lin, H; Mathias, RA; Metcalf, GA; Muzny, DM; Pitsillides, AN; Veeraraghavan, N; Yanek, LR1
Dieplinger, B; Haltmayer, M; Mueller, T; Poelz, W1
Campbell, CL; Oestreich, JH; Smyth, SS1
Fox, SC; Heptinstall, S; May, JA; Neubert, U; Shah, A1
Gluckman, TJ; Jani, JT; Kickler, TS; Laws, K; Nazarian, SM; Rade, JJ; Thompson, JB1
Abraham, D; Burg, MM; Chaplin, W; Kuruvilla, S; Shimbo, D; Wasson, LT1
Chen, Q; Cui, B; Ferro, A; Han, Y; Huang, Y; Ji, Y; Jiang, Q; Liu, N; Liu, Y; Mi, Q; Wang, L; Wu, Y1
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giglioli, C; Giusti, B; Gori, AM; Marcucci, R; Paniccia, R; Valente, S1
Bernlochner, I; Braun, S; Jaitner, J; Kastrati, A; Mehilli, J; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Steinhubl, S; von Beckerath, N1
Bartko, J; Firbas, C; Jilma, B; Schuetz, M; Schwameis, M; Siller-Matula, J; Spiel, AO; Weigl, M1
Kameda, S; Kokubo, Y; Mitsuguro, M; Miyata, T; Okamoto, A; Sakata, T; Sano, M1
Carolei, A; Ciancarelli, I; De Amicis, D; Di Massimo, C; Tozzi Ciancarelli, MG1
Behr, T; Behr, W; Kuch, B; von Scheidt, W1
Combescure, C; de Moerloose, P; Fontana, P; Reny, JL; Sanchez, JC; Zufferey, A1
Boĭchenko, ES; Dubinskaia, RÉ; Khoseva, EN; Kiseleva, NV; Lukina, IuV; Martsevich, SIu; Tolpygina, SN; Voronina, VP1
Chen, W; McEwen, BJ; Morel-Kopp, MC; Tofler, GH; Ward, CM1
Condren, R; Dinan, T; Hillmann, A; Kenny, D; Ryan, M; Thakore, JH; Walsh, MT1
Bhatt, DL; Topol, EJ1
Buyukkececi, F; Dereli, D; Guney, E; Ozgen, G; Yilmaz, C1
Bhatt, DL; Jneid, H1
Kelly, AB; Levy, JH; Szlam, F; Tanaka, KA; Vega, JD1
Kroner, C; Rechner, AR1
Ault, KA; D'Agostino, RB; Levy, D; Lipinska, I; Massaro, JM; Mittleman, MA; Mukamal, KJ; Sutherland, PA; Tofler, GH1
Becker, DM; Becker, LC; Bray, PF; Faraday, N; Herrera-Galeano, JE; Moy, TF; Segal, J; Vaidya, D; Yanek, LR1
Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A1
Hawley, JA; Spargo, FJ1
Fitzgerald, DJ; Maree, AO1
Akkerman, JW; de Lange, DW; Gorter, G; Kraaijenhagen, RJ; van de Wiel, A; Verhoef, S1
Alekseev, AE; Hodgson-Zingman, DM; Terzic, A; Zingman, LV1
Boyer, JL; Crean, C; Durham, T; Fox, AW; Johnson, FL; Kellerman, DJ; Krishnamoorthy, R; Leese, PT1
Christie, DJ; Gorman, RT; Kottke-Marchant, K1
Ardo, J; Motovska, Z; Skrakova, M; Sujanova, Z; Widimsky, P; Wimmerova, S1
Alfonso, F; Angiolillo, DJ1
Dörner, A; Schultheiss, HP1
Bestehorn, HP; Büttner, HJ; Frundi, D; Hochholzer, W; Neumann, FJ; Stratz, C; Trenk, D; Valina, CM1
Engelhardt, A; Lask, S; Mügge, A; Neubauer, H1
Buring, JE; Hennekens, CH; Lipinska, I; Ridker, PM; Tofler, GH1
Nakajima, Y; Nakashima, M; Saniabadi, AR; Takeich, S; Umemura, K; Yukawa, N1
Puri, RN1
D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; Lipinska, I; Muller, JE; Myers, RH; O'Donnell, CJ; Rao, VS; Schmitz, C; Silbershatz, H; Sutherland, PA; Tofler, GH1
Agteresch, HJ; Dagnelie, PC; van den Berg, JW; Wilson, JH1
Fitzgerald, DJ; Quinn, MJ1
Levine, S; Mancini, D; McCully, K1
Afanasjeva, G; Avdonin, P; Baskova, I; Berezhnoy, S; Gabbasov, Z; Popov, E; Zavalova, L1
D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; Lipinska, I; Mittleman, M; Muller, JE; O'Donnell, CJ; Sutherland, PA; Tofler, GH1
Jobin, F1
Heine, H; Heinemann, L; Norden, C; Stepanauskas, M1
Didisheim, P; Kobayashi, I; Yamazaki, H1
Cohn, PF; Erikssen, J; Sandvik, L; Stormorken, H; Thaulow, E1
Aron, L; Hertzeanu, H; Platsker, J1
Erney, TP; Mathien, GM; Ogilvie, RW; Terjung, RL1
Hoak, JC; Wu, KK1

Reviews

14 review(s) available for adenosine diphosphate and Cardiovascular Diseases

ArticleYear
Pharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic review.
    Clinical cardiology, 2013, Volume: 36, Issue:4

    Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Drug Resistance; Gastrointestinal Diseases; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Receptors, Purinergic P2Y12; Ticlopidine

2013
P2Y12 receptors: structure and function.
    Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13 Suppl 1

    Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cardiovascular Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Protein Conformation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Structure-Activity Relationship

2015
Pharmacology and structure of P2Y receptors.
    Neuropharmacology, 2016, Volume: 104

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain; Cardiovascular Diseases; Humans; Microglia; Neurodegenerative Diseases; Neurons; Platelet Aggregation; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y; Uridine Triphosphate

2016
Scientific and therapeutic advances in antiplatelet therapy.
    Nature reviews. Drug discovery, 2003, Volume: 2, Issue:1

    Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Cardiovascular Diseases; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Single Nucleotide

2003
Advances in antiplatelet therapy.
    Expert opinion on emerging drugs, 2003, Volume: 8, Issue:2

    Topics: Adenosine Diphosphate; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboxane A2

2003
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Circulation, 2007, Apr-24, Volume: 115, Issue:16

    Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure

2007
ATP-sensitive potassium channels: metabolic sensing and cardioprotection.
    Journal of applied physiology (Bethesda, Md. : 1985), 2007, Volume: 103, Issue:5

    Topics: Action Potentials; Adenosine Diphosphate; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Cardiovascular Diseases; Diffusion; Energy Metabolism; Homeostasis; Humans; Ion Channel Gating; KATP Channels; Models, Cardiovascular; Myocardium; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Signal Transduction; Sulfonylurea Receptors

2007
Adenine nucleotide translocase in the focus of cardiovascular diseases.
    Trends in cardiovascular medicine, 2007, Volume: 17, Issue:8

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Apoptosis; Cardiovascular Diseases; Gene Expression; Humans; Mitochondrial ADP, ATP Translocases; Myocardial Ischemia; Myocardium; Oxidative Phosphorylation

2007
Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms.
    The international journal of biochemistry & cell biology, 1998, Volume: 30, Issue:10

    Topics: Adenosine Diphosphate; Cardiovascular Diseases; Cerebrovascular Disorders; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Hemostasis; Humans; Phospholipases A; Phospholipases A2; Platelet Activation; Thrombin

1998
Adenosine triphosphate: established and potential clinical applications.
    Drugs, 1999, Volume: 58, Issue:2

    Topics: Adenosine Diphosphate; Anesthesia; Animals; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Lung Diseases; Neoplasms

1999
Ticlopidine and clopidogrel.
    Circulation, 1999, Oct-12, Volume: 100, Issue:15

    Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bone Marrow Diseases; Carbamazepine; Cardiovascular Diseases; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Interactions; Hemorrhage; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Phenytoin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Safety; Stents; Theophylline; Thrombolytic Therapy; Ticlopidine

1999
Nuclear magnetic resonance spectroscopy: its role in providing valuable insight into diverse clinical problems.
    Chest, 1999, Volume: 116, Issue:5

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Cardiovascular Diseases; Energy Metabolism; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Muscle, Skeletal; Phosphocreatine; Phosphorus; Respiratory Physiological Phenomena; Respiratory Tract Diseases

1999
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    L'union medicale du Canada, 1976, Volume: 105, Issue:8

    Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; In Vitro Techniques; Indomethacin; Oxyphenbutazone; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Time Factors

1976
[Prostaglandins in the cardio-vascular system].
    Harefuah, 1985, Volume: 109, Issue:5-6

    Topics: Adenosine Diphosphate; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Cyclic AMP; Cytochrome P-450 Enzyme System; Epoprostenol; Humans; Intramolecular Oxidoreductases; Prostaglandins; Thromboxane A2

1985

Trials

11 trial(s) available for adenosine diphosphate and Cardiovascular Diseases

ArticleYear
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study.
    Pharmacological research, 2015, Volume: 97

    Topics: Adenosine Diphosphate; Aged; Capsules; Cardiovascular Diseases; Chemistry, Pharmaceutical; Double-Blind Method; Female; Glucosides; Humans; Male; Middle Aged; Phenols; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Treatment Outcome

2015
Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Thrombosis and haemostasis, 2009, Volume: 101, Issue:2

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Diseases; Cell Adhesion Molecules; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reproducibility of Results; Sensitivity and Specificity; Stents; Ticlopidine

2009
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial.
    Thrombosis and haemostasis, 2011, Volume: 105, Issue:4

    Topics: Adenosine Diphosphate; Adolescent; Adult; Arachidonic Acid; Blood Platelets; Cardiovascular Diseases; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; P-Selectin; Peptide Fragments; Platelet Aggregation; Recombinant Proteins; Ristocetin; Sex Factors; Thrombosis

2011
Moderate consumption of red wine and human platelet responsiveness.
    Thrombosis research, 2011, Volume: 128, Issue:2

    Topics: Adenosine Diphosphate; Adult; Alcohol Drinking; Blood Platelets; Cardiovascular Diseases; Collagen; Humans; Male; Oxidative Stress; Platelet Aggregation; Platelet Count; Wine; Young Adult

2011
[Comparative evaluation of antiplatelet efectiveness drugs of original and reproduced enteric forms of acetylsalicylic acid (clinical study ICAR))].
    Kardiologiia, 2012, Volume: 52, Issue:1

    Topics: Adenosine Diphosphate; Administration, Oral; Aged; Aspirin; Cardiovascular Diseases; Dosage Forms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Therapeutic Equivalency; Treatment Outcome

2012
Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease.
    Seminars in thrombosis and hemostasis, 2013, Volume: 39, Issue:1

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Blood Platelets; Cardiovascular Diseases; Dietary Supplements; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Eicosapentaenoic Acid; Epinephrine; Fatty Acids, Omega-3; Humans; Middle Aged; Platelet Activation; Platelet Aggregation; Young Adult

2013
Sex differences in platelet reactivity and response to low-dose aspirin therapy.
    JAMA, 2006, Mar-22, Volume: 295, Issue:12

    Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Cardiovascular Diseases; Collagen; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Regression Analysis; Sex Factors

2006
Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.
    Platelets, 2007, Volume: 18, Issue:5

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adolescent; Adult; Bleeding Time; Blood Platelets; Cardiovascular Diseases; Cohort Studies; Double-Blind Method; Female; Hemostasis; Humans; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prothrombin Time; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12

2007
Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
    Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 150, Issue:4

    Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Case-Control Studies; Cations; Drug Resistance; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Propyl Gallate; Sensitivity and Specificity

2007
Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:1

    Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrroles; Simvastatin; Stents; Ticlopidine; Time Factors; Treatment Outcome

2008
Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Journal of cardiovascular risk, 1996, Volume: 3, Issue:2

    Topics: Adenosine Diphosphate; Administration, Oral; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Double-Blind Method; Drug Administration Schedule; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Radioimmunoassay; Risk Factors; Thromboxanes

1996

Other Studies

51 other study(ies) available for adenosine diphosphate and Cardiovascular Diseases

ArticleYear
Impact of the
    Pharmacogenomics, 2022, Volume: 23, Issue:11

    Topics: Adenosine Diphosphate; Aspirin; Cardiovascular Diseases; China; Clopidogrel; Humans; Hyperglycemia; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Receptors, Cell Surface

2022
Chaperone-mediated autophagy attenuates H
    Cell biology international, 2022, Volume: 46, Issue:11

    Topics: Adenosine Diphosphate; Apoptosis; Autophagy; Cardiovascular Diseases; Chaperone-Mediated Autophagy; Humans; Hydrogen Peroxide; Lysosomal Membrane Proteins; Lysosomes; Myocytes, Cardiac; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Ribose

2022
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen.
    Molecules (Basel, Switzerland), 2023, Mar-02, Volume: 28, Issue:5

    Topics: Adenosine Diphosphate; Animals; Apigenin; Arachidonic Acid; Cardiovascular Diseases; Fibrinolytic Agents; Mice; Mice, Inbred C57BL; Olive Oil; Platelet Aggregation; Platelet Aggregation Inhibitors

2023
Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.
    NMR in biomedicine, 2020, Volume: 33, Issue:5

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Butyrates; Cardiovascular Diseases; Energy Metabolism; Hemodynamics; Hydrolysis; Magnetic Resonance Spectroscopy; Male; Metabolic Diseases; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Contraction; Thermodynamics

2020
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.
    European journal of clinical investigation, 2020, Volume: 50, Issue:11

    Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Cardiovascular Diseases; Clopidogrel; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prognosis; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Stroke; Survival Rate; Ticagrelor

2020
To Have and Have Not: Intrinsic Platelet Hyperreactivity?
    Journal of the American Heart Association, 2018, 03-03, Volume: 7, Issue:5

    Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Diseases; Humans; Longitudinal Studies; Ticlopidine

2018
The in vitro effect of antirheumatic drugs on platelet function.
    Platelets, 2020, Volume: 31, Issue:2

    Topics: Adalimumab; Adenosine Diphosphate; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Blood Platelets; Cardiovascular Diseases; Collagen; Crotonates; Flow Cytometry; Humans; Hydroxybutyrates; In Vitro Techniques; Nitriles; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prednisolone; Risk Factors; Toluidines

2020
Preserved thrombin-inducible platelet activation in thienopyridine-treated patients.
    European journal of clinical investigation, 2013, Volume: 43, Issue:7

    Topics: Adenosine Diphosphate; Aged; Angioplasty; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Female; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Peptide Fragments; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Thrombin; Ticlopidine

2013
Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Atherosclerosis, 2014, Volume: 232, Issue:1

    Topics: Adenosine Diphosphate; Aged; Angioplasty; Angioplasty, Balloon, Coronary; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Monocytes; P-Selectin; Peptide Fragments; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Stents; Ticlopidine

2014
Detection of clopidogrel resistance using ADP induced aggregometry with specific inhibitor PGE1.
    Clinical laboratory, 2014, Volume: 60, Issue:9

    Topics: Adenosine Diphosphate; Adult; Aged; Alprostadil; Cardiovascular Diseases; Clopidogrel; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Ticlopidine; Treatment Outcome

2014
Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis.
    Atherosclerosis, 2014, Volume: 237, Issue:2

    Topics: Adenosine Diphosphate; Aged; Animals; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Female; Flow Cytometry; Humans; Integrin beta3; Leukocytes; Male; Mice; Middle Aged; Oligopeptides; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Sex Factors

2014
Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation.
    Thrombosis and haemostasis, 2015, Volume: 114, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adolescent; Adult; Alleles; Amino Acid Substitution; Animals; Arachidonic Acid; Cardiovascular Diseases; Collagen; Connexins; Gene Frequency; Genotype; Humans; Male; Mefloquine; Mice, Knockout; Nerve Tissue Proteins; Peptide Fragments; Platelet Aggregation; Polymorphism, Single Nucleotide; Probenecid; Purinergic P2X Receptor Antagonists; Recombinant Fusion Proteins; Signal Transduction; Transfection; Young Adult

2015
Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-'Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo.
    Drug metabolism letters, 2016, Volume: 10, Issue:3

    Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiovascular Diseases; Disease Models, Animal; Hypoxanthine; Isoproterenol; Rats; Rats, Sprague-Dawley; Uric Acid

2016
Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
    Platelets, 2016, Volume: 27, Issue:8

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Comorbidity; Extracellular Vesicles; Humans; Middle Aged; Phospholipids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Tartrate-Resistant Acid Phosphatase

2016
Exercise Training positively modulates the Ectonucleotidase Enzymes in Lymphocytes of Metabolic Syndrome Patients.
    International journal of sports medicine, 2016, Volume: 37, Issue:12

    Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Cardiovascular Diseases; Exercise; Female; Humans; Lymphocytes; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Time Factors

2016
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after
    American heart journal, 2017, Volume: 183

    Topics: Adenosine; Adenosine Diphosphate; Aged; Cardiovascular Diseases; Clopidogrel; Drug Substitution; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Patient Preference; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P1 Receptor Antagonists; Ticagrelor; Ticlopidine

2017
Whole exome sequencing in the Framingham Heart Study identifies rare variation in HYAL2 that influences platelet aggregation.
    Thrombosis and haemostasis, 2017, 06-02, Volume: 117, Issue:6

    Topics: Adenosine Diphosphate; Adult; Alleles; Blood Platelets; Cardiovascular Diseases; Cell Adhesion Molecules; Cohort Studies; Epinephrine; Exome; Exome Sequencing; Female; Genotype; GPI-Linked Proteins; Humans; Hyaluronoglucosaminidase; Male; Massachusetts; Membrane Proteins; Middle Aged; Mutation; Phosphoproteins; Platelet Aggregation; Polymorphism, Genetic; Population Groups; Protein Transport

2017
Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2009, Volume: 15, Issue:6

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clopidogrel; Collagen; Electric Impedance; Epinephrine; Female; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Activation; Platelet Function Tests; Sensitivity and Specificity; Ticlopidine

2009
Platelet function analysis: at the edge of meaning.
    Thrombosis and haemostasis, 2009, Volume: 101, Issue:2

    Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Diseases; Cell Adhesion Molecules; Clopidogrel; Drug Resistance; Humans; Microfilament Proteins; Patient Selection; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reproducibility of Results; Stents; Ticlopidine

2009
Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
    Platelets, 2009, Volume: 20, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Drug Monitoring; Female; Flow Cytometry; Humans; Male; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Tissue Fixation

2009
Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy.
    Thrombosis research, 2010, Volume: 126, Issue:5

    Topics: Adenosine Diphosphate; Aspirin; Biomarkers; Blood Platelets; Cardiovascular Diseases; Cohort Studies; Collagen; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies

2010
Hostility and platelet reactivity in individuals without a history of cardiovascular disease events.
    Psychosomatic medicine, 2009, Volume: 71, Issue:7

    Topics: Adenosine Diphosphate; Aggression; Blood Platelets; Cardiovascular Diseases; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Female; Hostility; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Count; Risk Factors

2009
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
    Heart (British Cardiac Society), 2010, Volume: 96, Issue:3

    Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiovascular Diseases; Clopidogrel; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Ticlopidine

2010
Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
    Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:1

    Topics: Adenosine Diphosphate; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon; Blood Platelets; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Female; Humans; Linear Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Stents; Ticlopidine

2010
Pyridoxine increases nitric oxide biosynthesis in human platelets.
    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 2009, Volume: 79, Issue:2

    Topics: Adenosine Diphosphate; Adult; Blood Platelets; Cardiovascular Diseases; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Pyridoxine; Thrombin; Young Adult

2009
High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:2

    Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arachidonic Acid; Cardiovascular Diseases; Chi-Square Distribution; Collagen; Drug Resistance; Drug Therapy, Combination; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome

2010
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:6

    Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinogen; Germany; Humans; Inflammation Mediators; Leukocyte Count; Linear Models; Logistic Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome

2010
Association of platelet aggregation with lipid levels in the Japanese population: the Suita study.
    Journal of atherosclerosis and thrombosis, 2011, Volume: 18, Issue:7

    Topics: Adenosine Diphosphate; Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Collagen; Female; Humans; Japan; Lipids; Male; Middle Aged; Platelet Aggregation

2011
Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2011, Volume: 100, Issue:10

    Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Drug Monitoring; Drug Resistance; Drug Substitution; Electrodes; Female; Germany; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Stents; Tetrazoles; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome

2011
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients.
    Thrombosis and haemostasis, 2011, Volume: 106, Issue:3

    Topics: Adenosine Diphosphate; Aged; Aspirin; Cardiovascular Diseases; Epinephrine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Activation; Platelet Function Tests; Practice Guidelines as Topic; Proteomics; Severity of Illness Index

2011
Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naïve, first-episode schizophrenic patients.
    Biological psychiatry, 2002, Nov-01, Volume: 52, Issue:9

    Topics: Adenosine Diphosphate; Adult; Aged; Antigens, CD; Antigens, Surface; Cardiovascular Diseases; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Risk Factors; Schizophrenia, Paranoid; Tetraspanin 30

2002
Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:5

    Topics: Adenosine Diphosphate; Adrenal Hyperplasia, Congenital; Adult; Androgens; Blood Platelet Disorders; Blood Platelets; Cardiovascular Diseases; Collagen; Epinephrine; Female; Humans; Insulin Resistance; Platelet Aggregation; Polycystic Ovary Syndrome

2003
Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Platelets, 2004, Volume: 15, Issue:5

    Topics: Adenosine; Adenosine Diphosphate; Aged; Aged, 80 and over; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Postoperative Hemorrhage; Purinergic P2 Receptor Antagonists; Retrospective Studies; Thrombelastography; Ticlopidine; Time Factors

2004
Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function.
    Thrombosis research, 2005, Volume: 116, Issue:4

    Topics: Adenosine Diphosphate; Anthocyanins; Cardiovascular Diseases; Collagen; Colon; Diet Therapy; Drug Synergism; Epinephrine; Flavonoids; Humans; Hydrogen Peroxide; Phenols; Platelet Activation; Polyphenols; Receptors, Thrombin

2005
Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study.
    Alcoholism, clinical and experimental research, 2005, Volume: 29, Issue:10

    Topics: Adenosine Diphosphate; Adult; Alcohol Drinking; Cardiovascular Diseases; Collagen; Cross-Sectional Studies; Epinephrine; Female; Genotype; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Prospective Studies; Risk Factors; Sex Characteristics; Smoking

2005
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95, Issue:4

    Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome

2006
It's all in the genes, so pick your parents wisely.
    Journal of applied physiology (Bethesda, Md. : 1985), 2006, Volume: 100, Issue:6

    Topics: Adenosine Diphosphate; Animals; Cardiovascular Diseases; Mitochondria, Muscle; Muscle, Skeletal; Physical Conditioning, Animal; Physical Endurance; Rats; Risk Factors

2006
Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox.
    Alcoholism, clinical and experimental research, 2007, Volume: 31, Issue:8

    Topics: Adenosine Diphosphate; Biotransformation; Calcium; Cardiovascular Diseases; Cytosol; Flavonoids; France; Fruit; Humans; Indicators and Reagents; Phenols; Phosphorylation; Plant Extracts; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Polyphenols; Receptors, Thrombin; Tyrosine; Vitis; Wine

2007
Molecule of the month. Ticagrelor.
    Drug news & perspectives, 2007, Volume: 20, Issue:4

    Topics: Adenosine; Adenosine Diphosphate; Cardiovascular Diseases; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Ticagrelor

2007
Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
    Platelets, 2008, Volume: 19, Issue:2

    Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Cardiovascular Diseases; Collagen; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests

2008
Platelet function testing and cardiovascular outcomes: steps forward in identifying the best predictive measure.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:4

    Topics: Adenosine Diphosphate; Cardiovascular Diseases; Clopidogrel; Flow Cytometry; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prognosis; Pyridines; ROC Curve; Sensitivity and Specificity; Ticlopidine; Treatment Outcome

2007
How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:2

    Topics: Adenosine Diphosphate; Aged; Algorithms; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Cardiovascular Diseases; Clinical Protocols; Clopidogrel; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Resistance; Feasibility Studies; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stents; Ticlopidine

2008
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:4

    Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Aspirin; Blood Platelets; Cardiovascular Diseases; Cilostazol; Death, Sudden, Cardiac; Disease Susceptibility; Dose-Response Relationship, Drug; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles

1998
Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:4

    Topics: Adenosine Diphosphate; Analysis of Variance; Antigens, Human Platelet; Cardiovascular Diseases; Demography; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Statistics, Nonparametric

1999
Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech.
    Platelets, 2000, Volume: 11, Issue:2

    Topics: Adenosine Diphosphate; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cardiovascular Diseases; Collagen; Dose-Response Relationship, Drug; Endopeptidases; Fibrinolytic Agents; Humans; Leeches; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors

2000
Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
    Circulation, 2001, Jul-10, Volume: 104, Issue:2

    Topics: Adenosine Diphosphate; Alleles; Antigens, Human Platelet; Cardiovascular Diseases; Epinephrine; Epitopes; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homozygote; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Vasoconstrictor Agents; von Willebrand Factor

2001
[Prevention of cardiovascular complications in manifest arteriosclerosis by the use of Micristine].
    Folia haematologica (Leipzig, Germany : 1928), 1979, Volume: 106, Issue:5-6

    Topics: Adenosine Diphosphate; Anticoagulants; Arteriosclerosis; Aspirin; Cardiovascular Diseases; Humans; Platelet Aggregation

1979
Cardiopulmonary dysfunctions caused by ADP-induced platelet aggregation.
    Japanese circulation journal, 1975, Volume: 39, Issue:6

    Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Pressure; Bradycardia; Busulfan; Cardiovascular Diseases; Heart Rate; Injections, Intra-Arterial; Injections, Intravenous; Male; Oxygen; Platelet Adhesiveness; Platelet Aggregation; Rats; Respiration; Respiratory Insufficiency; Sinoatrial Block; Spleen; Splenectomy; Time Factors

1975
Blood platelet count and function are related to total and cardiovascular death in apparently healthy men.
    Circulation, 1991, Volume: 84, Issue:2

    Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Electrocardiography; Exercise Test; Humans; Male; Platelet Aggregation; Platelet Count; Prospective Studies; Smoking

1991
Peripheral adaptations to low blood flow in muscle during exercise.
    The American journal of cardiology, 1988, Sep-09, Volume: 62, Issue:8

    Topics: Adaptation, Physiological; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Capillaries; Cardiovascular Diseases; Extremities; Humans; Mitochondria, Muscle; Muscles; Oxygen Consumption; Physical Exertion; Regional Blood Flow

1988
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.
    Lancet (London, England), 1974, Oct-19, Volume: 2, Issue:7886

    Topics: Adenosine Diphosphate; Adolescent; Adult; Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Cell Count; Blood Specimen Collection; Cardiovascular Diseases; Formaldehyde; Humans; In Vitro Techniques; Infusions, Parenteral; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Thrombin; Thromboembolism

1974